Research Alliance Corporation IV (RACD)
| Market Cap | 97.08M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 9.10M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,070 |
| Open | 11.26 |
| Previous Close | 11.26 |
| Day's Range | 10.65 - 11.42 |
| 52-Week Range | 10.00 - 13.64 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About RACD
Research Alliance Corporation IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, or other similar business combination. The company was incorporated in 2026 and is based in New York, New York.
News
Research Alliance Corporation IV Class A Ordinary Shares trading resumes
09:45 EDT Research Alliance Corporation IV (RACD) Class A Ordinary Shares trading resumes
Research Alliance Corporation IV Class A Ordinary Shares trading halted, volatility trading pause
09:40 EDT Research Alliance Corporation IV (RACD) Class A Ordinary Shares trading halted, volatility trading pause
RESEARCH ALLIANCE CORPORATION IV ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING
NEW YORK, July 13, 2026 /PRNewswire/ -- Research Alliance Corporation IV (the "Company"), a special purpose acquisition company, announced today the pricing of its initial public offering of 7,500,000...
Research Alliance IV IPO Registration Document (S-1)
Research Alliance IV has filed to go public with an IPO on the NASDAQ
RA Capital-backed SPAC Research Alliance Corp. IV files for a $75 million IPO, targeting healthcare
Research Alliance Corporation IV, the fourth blank check company formed by RA Capital targeting healthcare, life sciences, and healthtech, filed on Monday with the SEC to raise up to $75 million in an...